Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia

This study is currently recruiting participants.
Verified September 2011 by Clinical Service, China
Sponsor:
Collaborators:
Harbin Institute of Hematology and Oncology
Shanghai Changzheng Hospital
Chinese PLA General Hospital
Affiliated Hospital to Academy of Military Medical Sciences
Wuhan Union Hospital, China
Beijing Chao Yang Hospital
Henan Provincial Hospital
Peking University Third Hospital
Information provided by (Responsible Party):
wangzhao, Clinical Service, China
ClinicalTrials.gov Identifier:
NCT01328236
First received: March 29, 2011
Last updated: September 21, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)